Vagus nerve stimulation in Lennox–Gastaut syndrome: Twenty‐four‐month data and experience from the CORE ‐ VNS study
Epilepsia · 2025-05 · 66 (5) · 1540-1549
DOI: 10.1111/epi.18289 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Epilepsia, online erschienen am 08.02.2025. Verfasst von Paul Lyons und 8 weiteren Autor:innen. Beteiligte Einrichtung: Virginia Comprehensive Epilepsy Program, Winchester, Virginia, USA. Hauptthemen laut MEDLINE: Vagus Nerve Stimulation, Lennox Gastaut Syndrome. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: LivaNova PLC.
Abstract (Originalsprache)
Objective
The drug‐resistant epilepsy associated with Lennox–Gastaut syndrome (LGS) has a long‐term effect on patients and is difficult to treat with conventional pharmacological and nonpharmacological therapies. Our objective is to demonstrate that adjunctive vagus nerve stimulation (VNS) can help manage the seizures associated with LGS.
Methods
CORE‐VNS (NCT03529045) is a prospective, multicenter, multinational observational study to collect data on seizure and nonseizure outcomes following treatment with VNS. Participants were identified as having a documented LGS diagnosis and received initial VNS implants. Baseline seizure frequency data and patient‐reported outcome measures were collected at 3, 6, 12, 24, and 36 months. This interim analysis compared baseline data to VNS therapy outcomes at 24 months, and the results are presented here.
Results
Sixty participants in the CORE‐VNS study had a diagnosis of LGS and received an initial implant of VNS. The population was geographically diverse: 31.7% European, 26.7% from the Americas, and 26.7% from the Western Pacific. The median age at implant was 11.8 years (range = 2.2–47.6), and only 26.7% of those diagnosed with LGS were >18 years of age. Most (70%) of the participants had severe cognitive impairment. The LGS participants failed a median of 6 antiseizure medications, and 83.3% had not undergone epilepsy surgery. The LGS responder rate (≥50% reduction in seizure frequency) at 24 months for focal and generalized seizures was 66.7% and 47.4%, respectively. Some participants (20%, 12/60) experienced a ≥80% reduction in total seizure frequency. VNS was well tolerated, with only 15% (9/60) reporting at least one treatment‐emergent adverse event, primarily cough, dysphonia, and oropharyngeal pain. Significance LGS participants who received adjunctive VNS therapy to manage seizures were predominantly severely cognitively impaired children. Reductions in seizure frequency, including those with drops, and the sustained nature of the response support VNS as a promising therapy in LGS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Virginia Comprehensive Epilepsy Program, Winchester, Virginia, USA.
- University of Tennessee Health Science Center and Le Bonheur Children's Hospital, Memphis, Tennessee, USA.
- LivaNova, Houston, Texas, USA.
- Department of Pediatrics, and Pediatric Neurology, St. Joseph's Children's Hospital, School of Medicine, University of South Florida, Tampa, Florida, USA.
- Comprehensive Epilepsy Center, Hawaii Pacific Neuroscience, Honolulu, Hawaii, USA.
- Allegheny General Hospital, Pittsburgh, Pennsylvania, USA.
ORCID-Profile: James Wheless, Ryan Verner
Förderung
- LivaNova PLC
Zitieren
APA
Lyons, P., Wheless, J., Verner, R., Ferreira, J., Liow, K., Valeriano, J., Motamedi, G., Giannicola, G., & Nichol, K. (2025). Vagus nerve stimulation in Lennox–Gastaut syndrome: Twenty‐four‐month data and experience from the CORE ‐ VNS study. Epilepsia, 66(5), 1540-1549. https://doi.org/10.1111/epi.18289
Vancouver
Lyons P, Wheless J, Verner R, Ferreira J, Liow K, Valeriano J, et al. Vagus nerve stimulation in Lennox–Gastaut syndrome: Twenty‐four‐month data and experience from the CORE ‐ VNS study. Epilepsia. 2025;66(5):1540-1549. doi:10.1111/epi.18289
BibTeX
@article{Lyons2025,
author = {Lyons, Paul and Wheless, James and Verner, Ryan and Ferreira, Jose and Liow, Kore and Valeriano, James and Motamedi, Gholam and Giannicola, Gaia and Nichol, Kathryn},
title = {Vagus nerve stimulation in Lennox–Gastaut syndrome: Twenty‐four‐month data and experience from the CORE ‐ VNS study},
journal = {Epilepsia},
year = {2025},
volume = {66},
number = {5},
pages = {1540--1549},
doi = {10.1111/epi.18289}
}
EUVIMED